• Tue. Oct 20th, 2020

Dimancherouge

Technology

Hydroxychloroquine

  • Home
  • Hydroxychloroquine does not counter SARS-CoV-2 in hamsters, high dose of favipiravir does: study — ScienceDaily

Hydroxychloroquine does not counter SARS-CoV-2 in hamsters, high dose of favipiravir does: study — ScienceDaily

Virologists from the KU Leuven Rega Institute in Belgium have shown that a treatment with the anti-malaria drug hydroxychloroquine does not limit SARS-CoV-2 coronavirus replication in hamsters. A high dose…

Taiwan Liposome Gets the Go-Ahead for a Hydroxychloroquine COVID-19 Study

Paula Bronstein / Getty Images News via Getty ImagesTaiwan Liposome Co. Ltd. (NASDAQ: TLC) shares shot up on Wednesday after the firm announced that it would be able to move…